Symbols

SIBN

SI-BONE·NASDAQ

--(--)

SIBN Profile

Si-Bone, Inc.

A developer of proprietary minimally invasive surgical implant system to treat sacroiliac joint dysfunction

Industry

Healthcare Equipment and Supplies

Established Date

03/18/2008

Listing Date

10/17/2018

Exchange

NASDAQ Stock Exchange

Full-time Employees

376

Fiscal Year Ends

12-31

Website

www.si-bone.com

Security Type

Common stock

Office address

471 El Camino Real, Suite 101, Santa Clara, California 95050

Business

Introduction

SI-BONE, Inc., was incorporated in Delaware on March 18, 2008. The company is a leader in the development of innovative procedural solutions for damaged bones, building on expertise in biomechanical design and anatomy-specific innovations. With its experience in additive manufacturing or 3 D printing developed in sacroiliac fusion, the company has established a technology platform that can now be expanded to meet critical unmet needs in thoracolumbar fixation and fusion and pelvic trauma. The company's products include a range of patented titanium implants and their implanted devices, as well as implantable bone products. Since the launch of the first generation iFuse in 2009, the company has launched several implant product lines, including iFuse 3 D in 2017, iFuse TORQ in 2021, iFuse Bedrock Granite in 2022, and iFuse INTRA and iFuse TORQ TNT in 2024.